MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Search

Quidel Corp

Fechado

14.17 -7.45

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.98

Máximo

15.34

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+100.72% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-193M

1B

Abertura anterior

21.62

Fecho anterior

14.17

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de abr. de 2026, 20:44 UTC

Ganhos

Costco Reports 11% Growth in March Sales

8 de abr. de 2026, 23:51 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de abr. de 2026, 23:51 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 de abr. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 de abr. de 2026, 22:56 UTC

Conversa de Mercado

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 de abr. de 2026, 22:45 UTC

Conversa de Mercado

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 de abr. de 2026, 22:17 UTC

Conversa de Mercado

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 de abr. de 2026, 21:52 UTC

Notícias Principais

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 de abr. de 2026, 21:24 UTC

Ganhos

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 de abr. de 2026, 21:01 UTC

Notícias Principais

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

8 de abr. de 2026, 20:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 de abr. de 2026, 20:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 de abr. de 2026, 20:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 de abr. de 2026, 20:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 de abr. de 2026, 20:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 de abr. de 2026, 20:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Oracle Responds to TRC Cap Mini-Tender Offer

8 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

8 de abr. de 2026, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 de abr. de 2026, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 de abr. de 2026, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 de abr. de 2026, 19:44 UTC

Ganhos

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 de abr. de 2026, 19:16 UTC

Conversa de Mercado

Hogs Follow Cutout Prices Lower -- Market Talk

8 de abr. de 2026, 19:02 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

8 de abr. de 2026, 19:02 UTC

Conversa de Mercado

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 de abr. de 2026, 18:58 UTC

Conversa de Mercado

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 de abr. de 2026, 18:51 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de abr. de 2026, 18:51 UTC

Conversa de Mercado

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 de abr. de 2026, 18:14 UTC

Notícias Principais

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 de abr. de 2026, 18:05 UTC

Notícias Principais

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

100.72% parte superior

Previsão para 12 meses

Média 30.75 USD  100.72%

Máximo 38 USD

Mínimo 25 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat